News

APP Pharma, a wholly subsidiary of Fresenius Kabi Pharmaceuticals, has further added six production lines for injectable products in the plant. At its Grand Island facility, the company

BAY 94-9343 consists of a Bayer HealthCare antibody that targets mesothelin with ImmunoGen’s DM4 cancer-cell killing agent attached using one of the company’s engineered linkers. Bayer HealthCare is

The company claims RegenErect is an effective, safe and natural alternative to other male enhancement products that help to achieve a more consistent and powerful sexual experience. The

CREON delayed-release capsules (pancreatic enzyme medicine) are indicated for the improving food digestion in people who cannot digest food properly because they have EPI. Abbott Global Pharmaceutical Development

The companies will work together for the development of new approaches to improve administration of several vaccines in development. As per the terms of the agreement, Arecor licenses

The web-based interface allows medical device manufacturers and pharmaceutical companies to remain compliant to complex regulatory requirements, improve business performance, and manage risk through a single-sourced solution. BSI

The transaction, which could be valued at close to $1bn by potential suitors, includes a combination of upfront payments, milestone-linked payments and royalties on sales of the drug,

Gentium‘s Defibrotide is an experimental drug, which is indicated as the treatment for veno-occlusive disease (VOD). Defibrotide has been awarded orphan drug designation from the European Commission both

The company has generated net income of $7.08m, compared to $3.42m for the same period in 2010. China Botanic’s income from operations was $8.03m, compared to $3.4m for